Late-stage study of first single-shot vaccine begins in U.S.

JOHNSON & JOHNSON is beginning a huge final study to try to prove if the single-dose vaccine can protect against the coronavirus. / COURTESY JOHNSON & JOHNSON/CHERYL GERBER
JOHNSON & JOHNSON is beginning a huge final study to try to prove if the single-dose vaccine can protect against the coronavirus. / COURTESY JOHNSON & JOHNSON/CHERYL GERBER
Johnson & Johnson is beginning a huge final study to try to prove if a single-dose COVID-19 vaccine can protect against the virus. The study starting Wednesday will be one of the world's largest coronavirus vaccine studies so far, testing the shot in 60,000 volunteers in the United States, South Africa, Argentina, Brazil, Chile, Colombia,…

Want More?

Subscribe or register with Providence Business News to keep reading.

REGISTER
for 2 more stories

Subscribe now for $1 for 4 weeks
Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -

No posts to display